Loading clinical trials...
Loading clinical trials...
A Prospective Study on the Modified DEP Regimen Induction Therapy in Lymphoma Induced Hemophagocytic Lymphohistiocytosis
Conditions
Interventions
Pegylated liposomal doxorubicin
Etoposide
+1 more
Locations
1
China
Beijing Friendship Hospital
Beijing, China
Start Date
August 31, 2019
Primary Completion Date
July 31, 2021
Completion Date
July 31, 2021
Last Updated
September 6, 2019
NCT03259230
NCT05841342
NCT01998633
NCT05384743
NCT01818908
NCT03742115
Lead Sponsor
Beijing Friendship Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions